Ebola vaccine is being tested on two women in a fast-tracked clinical trial (Twitter/@YahooNews)

To meet the demand for an effective Ebola vaccine, a fast tracked clinical trial was initiated to test a drug that could potentially prevent Ebola from infecting the body. Currently, two women have been injected with the experimental vaccine.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the NIH, said, “There is an urgent need for a protective Ebola vaccine, and it important to establish that a vaccine is safe and spurs the immune system to react in a way necessary to protect against infection.”

Additional Ebola vaccine trials will be held in September at the University of Oxford in England, and centers in Gambia and Mali. These trials will test around 140 more patients.

Read More at ABC News.

Reach Web Producer Niki Hashemi here and follow her on Twitter.